Unlock the potential of nanotechnology
Magnetic Ion Channel Activation
Bringing magnetic nanotechnology advances to regenerative medicine and drug discovery.
A nanoverse full of potential
MICA nanotechnology can be used in the active treatment through our cell therapy solution, utilising the potential of stem cells to treat anything from spinal injuries and diseases, to tendon damage. It can be used in the screening of drugs through inducing a dynamic environment for drug screening through our patented DYNASCREEN platform. Further capitalising on the possibilities of nanotechnology, we have developed a bioreactor capable of growing cells and organoids in a dynamic, mechanically stimulated environment to open the window into disease, development and discovery.
Possible therapy areas
MICA Cell Therapy has a wide-reaching potential to improve the lives of millions of people. Below are some of the therapy areas which could benefit from our technology.
Spinal Fusion
MICA Cell Therapy can be used as a standalone solution to the fusion of vertebrae in situ, turning an invasive and risky surgical procedure into a superficial injection, or in conjuncture with existing spinal cages to aid in their effectiveness.
1
Orthopaedic Device Fixation
The Cell Therapy could be used as a fixation method of orthopaedic implants, such as hip replacement devices, in patients with low bone density.
2
Tendon Repair
Biological in situ repair of tendons may be possible using MICA Cell Therapy- removing, or reducing, the need for surgical tendon repair or transplant.
3
Acute Spinal Cord Repair
Acute Spinal Cord damage could be treated by growing nerve cells in the damaged area using the minimally-invasive MICA cell therapy.
4
Craniomaxillofacial Repair
Notoriously difficult, craniomaxillofacial repair can be aided using the nanotechnology-aided Cell Therapy.
5
DYNASCREEN™
FOCUS
Our patented drug screening platform establishes an industry-first standardised assay to assess drug absorption. Dynamic drug absorption in Caco-2 cells can be up to 150 % greater than static absorption assays. Phase 4 compounds which showed limited absorption in static assays showed good absorption in our DYNASCREEN assays.